Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
8.77
+0.45 (5.41%)
At close: Aug 23, 2024, 4:00 PM
8.78
+0.01 (0.11%)
After-hours: Aug 23, 2024, 7:25 PM EDT
Vir Biotechnology Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 78.88 | 86.18 | 1,616 | 1,095 | 76.37 | 8.09 | Upgrade
|
| Revenue Growth (YoY) | -83.93% | -94.67% | 47.51% | 1334.39% | 843.86% | -24.16% | Upgrade
|
| Cost of Revenue | 448.59 | 572.15 | 620.97 | 513.87 | 301.58 | 148.47 | Upgrade
|
| Gross Profit | -369.71 | -485.97 | 994.83 | 581.54 | -225.21 | -140.38 | Upgrade
|
| Selling, General & Admin | 148.35 | 174.05 | 161.76 | 160.79 | 70.94 | 37.6 | Upgrade
|
| Operating Expenses | 148.35 | 174.05 | 161.76 | 160.79 | 70.94 | 37.6 | Upgrade
|
| Operating Income | -518.05 | -660.02 | 833.07 | 420.75 | -296.15 | -177.98 | Upgrade
|
| Interest & Investment Income | 82.8 | 86.99 | 28.09 | 0.44 | 2.84 | 8.51 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.43 | -8.99 | 4.26 | -9.44 | -4.47 | -5.06 | Upgrade
|
| EBT Excluding Unusual Items | -436.68 | -582.02 | 865.42 | 411.75 | -297.78 | -174.53 | Upgrade
|
| Merger & Restructuring Charges | -26.76 | -5.9 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -9.19 | -21.89 | -111.14 | 138.05 | - | - | Upgrade
|
| Asset Writedown | -13.97 | -17.36 | - | - | -0.83 | - | Upgrade
|
| Other Unusual Items | -5.67 | -1.02 | - | - | - | - | Upgrade
|
| Pretax Income | -492.27 | -628.19 | 754.28 | 549.8 | -298.61 | -174.53 | Upgrade
|
| Income Tax Expense | -9.23 | -13.08 | 238.44 | 21.22 | 0.05 | 0.15 | Upgrade
|
| Earnings From Continuing Operations | -483.04 | -615.12 | 515.84 | 528.58 | -298.67 | -174.68 | Upgrade
|
| Minority Interest in Earnings | - | 0.06 | - | - | - | - | Upgrade
|
| Net Income | -483.04 | -615.06 | 515.84 | 528.58 | -298.67 | -174.68 | Upgrade
|
| Net Income to Common | -483.04 | -615.06 | 515.84 | 528.58 | -298.67 | -174.68 | Upgrade
|
| Net Income Growth | - | - | -2.41% | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 135 | 134 | 133 | 130 | 119 | 30 | Upgrade
|
| Shares Outstanding (Diluted) | 135 | 134 | 135 | 133 | 119 | 30 | Upgrade
|
| Shares Change (YoY) | 1.32% | -0.50% | 1.03% | 11.98% | 292.62% | 295.88% | Upgrade
|
| EPS (Basic) | -3.58 | -4.59 | 3.89 | 4.07 | -2.51 | -5.76 | Upgrade
|
| EPS (Diluted) | -3.58 | -4.59 | 3.83 | 3.96 | -2.51 | -5.76 | Upgrade
|
| EPS Growth | - | - | -3.28% | - | - | - | Upgrade
|
| Free Cash Flow | -458.78 | -800.36 | 1,595 | -69.41 | -197.49 | -138.57 | Upgrade
|
| Free Cash Flow Per Share | -3.40 | -5.97 | 11.83 | -0.52 | -1.66 | -4.57 | Upgrade
|
| Gross Margin | - | - | 61.57% | 53.09% | -294.90% | - | Upgrade
|
| Operating Margin | -656.79% | -765.87% | 51.56% | 38.41% | -387.79% | -2199.72% | Upgrade
|
| Profit Margin | -612.40% | -713.69% | 31.92% | 48.25% | -391.09% | -2158.98% | Upgrade
|
| Free Cash Flow Margin | -581.64% | -928.71% | 98.73% | -6.34% | -258.60% | -1712.67% | Upgrade
|
| EBITDA | -500.21 | -640.57 | 839.85 | 426.56 | -290.71 | -174.69 | Upgrade
|
| EBITDA Margin | - | - | 51.98% | 38.94% | - | - | Upgrade
|
| D&A For EBITDA | 17.84 | 19.45 | 6.78 | 5.81 | 5.44 | 3.29 | Upgrade
|
| EBIT | -518.05 | -660.02 | 833.07 | 420.75 | -296.15 | -177.98 | Upgrade
|
| EBIT Margin | - | - | 51.56% | 38.41% | - | - | Upgrade
|
| Effective Tax Rate | - | - | 31.61% | 3.86% | - | - | Upgrade
|
| Revenue as Reported | 78.88 | 86.18 | 1,616 | 1,095 | 76.37 | 8.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.